{"address1": "1901 West 47th Place", "city": "Kansas City", "state": "KS", "zip": "66205", "country": "United States", "phone": "913 942 2300", "website": "https://www.cingulate.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Raul R. Silva M.D.", "age": 66, "title": "Co-Founder, Executive VP & Chief Science Officer", "yearBorn": 1958, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Thomas  Dalton", "title": "Vice President of Investor & Public Relations", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.3, "open": 4.43, "dayLow": 4.23, "dayHigh": 4.43, "regularMarketPreviousClose": 4.3, "regularMarketOpen": 4.43, "regularMarketDayLow": 4.23, "regularMarketDayHigh": 4.43, "payoutRatio": 0.0, "beta": -0.844, "forwardPE": -0.5813953, "volume": 106042, "regularMarketVolume": 106042, "averageVolume": 136755, "averageVolume10days": 87600, "averageDailyVolume10Day": 87600, "bid": 4.17, "ask": 4.35, "bidSize": 1, "askSize": 1, "marketCap": 15502555, "fiftyTwoWeekLow": 1.8, "fiftyTwoWeekHigh": 20.83, "fiftyDayAverage": 4.2627, "twoHundredDayAverage": 4.929835, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3846015, "profitMargins": 0.0, "floatShares": 3203367, "sharesOutstanding": 3647660, "sharesShort": 92894, "sharesShortPriorMonth": 133391, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0255, "heldPercentInsiders": 0.02813, "heldPercentInstitutions": 0.02407, "shortRatio": 0.95, "shortPercentOfFloat": 0.026199998, "impliedSharesOutstanding": 3647660, "bookValue": 3.954, "priceToBook": 1.0748609, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -15545737, "trailingEps": -10.2, "forwardEps": -7.31, "lastSplitFactor": "1:12", "lastSplitDate": 1723161600, "enterpriseToEbitda": -0.257, "52WeekChange": -0.6690031, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 4.25, "targetHighPrice": 62.0, "targetLowPrice": 8.0, "targetMeanPrice": 25.5, "targetMedianPrice": 16.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 10040149, "totalCashPerShare": 3.126, "ebitda": -14987922, "totalDebt": 234174, "debtToEquity": 1.945, "returnOnEquity": -6.016, "grossProfits": -9445265, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CING", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "preMarketTime": 1743589823, "regularMarketTime": 1743537602, "marketState": "PRE", "regularMarketChangePercent": -1.1627951, "regularMarketPrice": 4.25, "shortName": "Cingulate Inc.", "longName": "Cingulate Inc.", "exchange": "NCM", "messageBoardId": "finmb_1674914781", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "preMarketChange": -0.05000019, "preMarketChangePercent": -1.176475, "preMarketPrice": 4.2, "regularMarketChange": -0.05000019, "regularMarketDayRange": "4.23 - 4.43", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 136755, "fiftyTwoWeekLowChange": 2.45, "fiftyTwoWeekLowChangePercent": 1.3611112, "fiftyTwoWeekRange": "1.8 - 20.83", "fiftyTwoWeekHighChange": -16.58, "fiftyTwoWeekHighChangePercent": -0.79596734, "fiftyTwoWeekChangePercent": -66.900314, "epsTrailingTwelveMonths": -10.2, "epsForward": -7.31, "epsCurrentYear": -2.66, "priceEpsCurrentYear": -1.5977443, "fiftyDayAverageChange": -0.012700081, "fiftyDayAverageChangePercent": -0.0029793512, "twoHundredDayAverageChange": -0.67983484, "twoHundredDayAverageChangePercent": -0.13790216, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-08", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638973800000, "displayName": "Cingulate", "trailingPegRatio": null}